Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Rolf Dieter, Kortmann"'
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Tucatinib (TUC), a HER2-directed tyrosine kinase inhibitor, is the first targeted drug demonstrating intracranial efficacy and significantly prolonged survival in metastatic HER2-positive breast cancer (BC) patients with brain met
Externí odkaz:
https://doaj.org/article/9cf7e6b94efd4a4a95a977a74d3e3670
Autor:
Gilles Palenzuela, Camille Schiffler, Didier Frappaz, Andreas Peyrl, Nicolas U. Gerber, Rolf-Dieter Kortmann, Michael Philippe, Martin Zimmermann, Matthew J. Murray, James C. Nicholson, Gabriele Calaminus, Cécile Faure-Conter
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundSIOP-CNS-GCT-II European trial was opened for the treatment of patients of any age with central nervous system germ cell tumour (CNS-GCT). Four courses of pre-irradiation chemotherapy were delivered. The influence of patient age on chemothe
Externí odkaz:
https://doaj.org/article/4149af07ff0b47839808459676854bde
Autor:
Lara Chavaz, Geert O. Janssens, Stephanie Bolle, Henry Mandeville, Monica Ramos-Albiac, Karen Van Beek, Helen Benghiat, Bianca Hoeben, Andres Morales La Madrid, Clemens Seidel, Rolf-Dieter Kortmann, Darren Hargrave, Lorenza Gandola, Emilia Pecori, Dannis G. van Vuurden, Veronica Biassoni, Maura Massimino, Christof M. Kramm, Andre O. von Bueren
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeThe aim of this study is to investigate the spectrum of neurological triad improvement in patients with diffuse intrinsic pontine glioma (DIPG) treated by re-irradiation (re-RT) at first progression.MethodsWe carried out a re-analysis of the S
Externí odkaz:
https://doaj.org/article/6c43db3ed77c4724ada36c5467265929
Autor:
Stephanie T. Jünger, Martin Mynarek, Inken Wohlers, Evelyn Dörner, Anja zur Mühlen, Natalia Velez-Char, Katja von Hoff, Stefan Rutkowski, Monika Warmuth-Metz, Rolf-Dieter Kortmann, Beate Timmermann, Sven Rahmann, Ludger Klein-Hitpass, Andre O. von Bueren, Torsten Pietsch
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Introduction Risk stratification of children with ependymomas of the posterior fossa in current therapeutic protocols is mainly based on clinical criteria. We aimed to identify independent outcome predictors for this disease entity by a syst
Externí odkaz:
https://doaj.org/article/b6f10fd32cfe498ea52b2120536a0527
Autor:
Ina Patties, Sonja Kallendrusch, Lisa Böhme, Eva Kendzia, Henry Oppermann, Frank Gaunitz, Rolf-Dieter Kortmann, Annegret Glasow
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-16 (2019)
Abstract Background Glioblastoma is the most common and aggressive brain tumour in adults with a median overall survival of only 14 months after standard therapy with radiation therapy (IR) and temozolomide (TMZ). In a novel multimodal treatment appr
Externí odkaz:
https://doaj.org/article/3e5fedde859f4e2caead25268b769921
Publikováno v:
Molecules, Vol 27, Iss 11, p 3384 (2022)
Multimodal treatment adding immunotherapy and photodynamic treatment (PDT) to standard therapy might improve the devastating therapeutic outcome of glioblastoma multiforme patients. As a first step, we provide investigations to optimize dendritic cel
Externí odkaz:
https://doaj.org/article/7599a11fff804ccdb6f8fda29cb872dc
Autor:
Sarah Peters, Julien Merta, Laura Schmidt, Danny Jazmati, Paul-Heinz Kramer, Cristoph Blase, Stephan Tippelt, Gudrun Fleischhack, Annika Stock, Brigitte Bison, Stefan Rutkowski, Torsten Pietsch, Rolf-Dieter Kortmann, Beate Timmermann
Publikováno v:
Neuro-Oncology. 24:1193-1202
Background Radiotherapy (RT) of ependymoma in children is an important part of the interdisciplinary treatment concept. However, feasibility and dose concepts are still under investigation, particularly in very young children. The aim of this study w
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]Literatur.
Autor:
Beate Timmermann, Christiane Matuschek, Annett Braesigk, Silke Frick, Stefan Rutkowski, Ralf Kitzing, Stefan Dietzsch, Kristin Gurtner, Julia Remmele, Denise Obrecht, Nicolas U. Gerber, Rolf-Dieter Kortmann, Karin Dieckmann, Tina Schlender, Montserrat Pazos, Martin Benesch, V. Lewitzki, Damien C. Weber, Clemens Seidel, Karolina Jablonska, Dirk Geismar, Martin Mynarek, Semi Harrabi, Albrecht Glück, Rudolf Schwarz
Publikováno v:
Dietzsch, Stefan; Braesigk, Annett; Seidel, Clemens; Remmele, Julia; Kitzing, Ralf; Schlender, Tina; Mynarek, Martin; Geismar, Dirk; Jablonska, Karolina; Schwarz, Rudolf; Pazos, Montserrat; Weber, Damien C; Frick, Silke; Gurtner, Kristin; Matuschek, Christiane; Harrabi, Semi Ben; Glück, Albrecht; Lewitzki, Victor; Dieckmann, Karin; Benesch, Martin; ... (2022). Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlentherapie und Onkologie, 198(3), pp. 282-290. Springer 10.1007/s00066-021-01822-0
Purpose In Germany, Austria, and Switzerland, pretreatment radiotherapy quality control (RT-QC) for tumor bed boost (TB) in non-metastatic medulloblastoma (MB) was not mandatory but was recommended for patients enrolled in the SIOP PNET5 MB trial bet
Autor:
Hans Theodor Eich, Normann Willich, Fenja Albrecht, Yvonne Ziert, Christiane Matuschek, Christian Rübe, Rolf-Dieter Kortmann, Diana Steinmann, Hans Christiansen, Beate Timmermann, Carmen Martini, Heidi Wolters
Publikováno v:
Strahlentherapie Und Onkologie
Purpose The aim of the study is to evaluate treatment-related acute and late eye toxicity associated with radiation therapy in childhood and adolescence as correlated with RT (radiotherapy) doses. Methods From 2001 to 2016, a total of 1725 children a